3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
2
Withdrawn
1
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Endocrine
2
Conditions
Neuroendocrine Tumors
52
Thyroid Neoplasms
19
Thyroid Cancer, Papillary
16
Carcinoma, Neuroendocrine
16
Pheochromocytoma
11
Adrenocortical Carcinoma
11
Thyroid Carcinoma, Anaplastic
10
Gastro-enteropancreatic neuroendocrine tumor
10
Small Cell Lung Carcinoma
9
Paraganglioma
9
Multiple Endocrine Neoplasia Type 1
9
Pituitary Neoplasms
8
Lung Neoplasms
8
Adenoma, Islet Cell
8
Sarcoma
7
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Medullary
6
Adenocarcinoma, Follicular
6
Colorectal Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma, Renal Cell
5
Carcinoma, Merkel Cell
5
Carcinoid Tumor
5
Somatostatinoma
4
Pancreatic Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Cholangiocarcinoma
4
Carcinoma, Hepatocellular
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Carcinoid Heart Disease
×
Endocrine
×
Clear all
NCT05064514
2026-05-08
TRICAR
Queen Mary University of London
Phase NA
Active not recruiting
15 enrolled
NCT03498040
2024-12-03
CRUSOE-NETs
Hospices Civils de Lyon
Active not recruiting
670 enrolled